understanding psa, pirads, tumor size, & location | answering youtube comments #59 | mark scholz, md
Published 2 years ago • 55K plays • Length 10:04
Download video MP4
Download video MP3
Similar videos
-
8:56
does #prostatecancer tumor size and location matter? | #markscholzmd #alexscholz | #pcri
-
4:13
prostate size & focal treatments | answering youtube comments #67 | mark scholz, md | pcri
-
4:45
inconclusive prostate mris, targeted biopsy, second opinions for pathology | mark scholz, md | pcri
-
2:12
small cell tumors and prostate cancer | answering youtube comments #29 | mark scholz, md
-
8:33
prostate imaging, high psa, and more | answering youtube comments #9 | mark scholz, md
-
3:40
what is free psa? | answering youtube comments #18 | mark scholz, md | pcri
-
4:12
prostate cancer mortality rate explained | answering youtube comments #48 | mark scholz, md | pcri
-
6:09
staging prostate cancer - mri, pirads, & psma | are biopsies still needed? | mark scholz, md | pcri
-
4:00
prostate cancer assays, opko 4k, selectmdx | answering youtube comments #38 | mark scholz, md | pcri
-
3:28
monitoring psa after radiation therapy | answering youtube comments #70 | mark scholz, md | pcri
-
3:34
methods of targeted biopsies | answering youtube comments | mark scholz, md | #21
-
8:24
interpreting high psa values & free psa | mark scholz, md | pcri
-
5:56
ultrasound-guided biopsies vs mri, dre vs psa | answering youtube comments #61 | mark scholz, md
-
14:09
how psma revolutionizes staging for #prostatecancer | #markscholzmd | #pcri
-
6:18
psma, mri, & micro-metastases | answering youtube comments #22 | mark scholz, md
-
5:34
low gleason score (6 or 7) high psa? | prostate cancer | mark scholz, md | pcri
-
6:39
psa recurrence: when should you treat? | ask a prostate expert, mark scholz, md
-
12:23
staging prostate cancer, psa screening, and what if you have a high psa? | mark scholz, md | pcri
-
3:31
side effects: sbrt, imrt, & brachytherapy | answering youtube comments, mark scholz, md | pcri #19
Clip.africa.com - Privacy-policy